ARCHIVE

• OTC NEWS IN BRIEF
  February 17, 2003

• Toyobo, Mitsui & Co Jointly Create TM Cell Research
  February 17, 2003

• Takara Bio, Cepheid Launch Bead-form PCR Reagent Worldwide
  February 17, 2003

• Shiro Hiruta to Take Helm of Asahi Kasei in April
  February 17, 2003

• Azwell Acquires Exclusive Domestic Marketing Rights to Speculite
  February 17, 2003

• Aventis Targets 25% Allergic Rhinitis Market Share for Allegra
  February 17, 2003

• Fuso Gets Marketing Rights to i-STAT Blood Analysis System
  February 17, 2003

• Generic Drug Use to Actively Be Promoted by Research Group
  February 17, 2003

• DIAGNOSTIC NEWS IN BRIEF
  February 17, 2003

• Teijin, Kyorin to Strengthen Business in Respiratory Field
  February 10, 2003

• Bio-derived Products Total 189 Ingredients
  February 10, 2003

• Aventis to Transfer Suvenyl Manufacturing Rights to Chugai
  February 10, 2003

• PFSB to Review Current Quality Reevaluation Program
  February 10, 2003

• DMS Seminar Discusses How to Build Collaboration in Distribution
  February 10, 2003

• Mochida's Drug Discovery Research Institute to Become Independent
  February 10, 2003

• REGULATORY NEWS IN BRIF
  February 10, 2003

• voluntary Agreement on Precautions in Use of OTC Drugs Revised
  February 10, 2003

• Sales of Seroquel to Reach \9.3 Bil. for FY2002
  February 10, 2003

• Korosho to Determine Lump-sum Fees According to Length of Hospital Stay
  February 10, 2003

• ACCJ Seminar Focuses on Early Discovery, Diagnosis of Breast Cancer
  February 10, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 619
• 620
• 621
• 622
• 623
• 624
• 625
• 626
• 627
• …
• Next ›
• 最終 »